Twist Bioscience
TWST
193 hedge funds and large institutions have $3.01B invested in Twist Bioscience in 2020 Q3 according to their latest regulatory filings, with 60 funds opening new positions, 56 increasing their positions, 58 reducing their positions, and 13 closing their positions.
362% more first-time investments, than exits
New positions opened: 60 | Existing positions closed: 13
150% more funds holding in top 10
Funds holding in top 10: 2 → 5 (+3)
79% more capital invested
Capital invested by funds: $1.68B → $3.01B (+$1.33B)
51% more call options, than puts
Call options by funds: $8.29M | Put options by funds: $5.48M
32% more funds holding
Funds holding: 146 → 193 (+47)
5.47% more ownership
Funds ownership: 83.43% → 88.9% (+5.5%)
3% less repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 58
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$94.4M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$56.4M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$45.1M |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
+$40.3M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$39.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$35.4M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$27.4M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$26.7M |
| 4 |
Millennium Management
New York
|
-$26.1M |
| 5 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
-$20M |
TWST Hedge Fund Activity: Q3 2020 in Review
193 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q3 2020, worth a combined $3.01B — up 79% from $1.68B a quarter earlier.
Buyers outnumbered sellers: 60 funds opened new TWST positions and 13 closed out — a net gain of 47 holders — while 56 added to existing stakes and 58 trimmed.
The largest buyer was ARK Investment Management, adding an estimated $94.4M. The largest seller was JP Morgan Chase, cutting an estimated $35.4M.
- 193 institutional investors held Twist Bioscience (TWST) as of Q3 2020, up from 146 in Q2 2020.
- Funds reported $3.01B of Twist Bioscience stock for Q3 2020, up 79% quarter-over-quarter.
- 60 funds opened new Twist Bioscience positions in Q3 2020 and 13 closed out, a net change of +47 holders.
- The largest Twist Bioscience buyer in Q3 2020 was ARK Investment Management, an estimated $94.4M added.
- The largest Twist Bioscience seller in Q3 2020 was JP Morgan Chase, an estimated $35.4M sold.
Based on aggregated 13F filings for Q3 2020.